0001769132-19-000001.txt : 20190228 0001769132-19-000001.hdr.sgml : 20190228 20190228162558 ACCESSION NUMBER: 0001769132-19-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20190228 DATE AS OF CHANGE: 20190228 EFFECTIVENESS DATE: 20190228 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Guide Therapeutics, Inc. CENTRAL INDEX KEY: 0001769132 IRS NUMBER: 832325333 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-333816 FILM NUMBER: 19643683 BUSINESS ADDRESS: STREET 1: 308 NORTHYARDS BLVD. NW STREET 2: STE B CITY: ATLANTA STATE: GA ZIP: 30013 BUSINESS PHONE: 404-937-3801 MAIL ADDRESS: STREET 1: 308 NORTHYARDS BLVD. NW STREET 2: STE B CITY: ATLANTA STATE: GA ZIP: 30013 D 1 primary_doc.xml X0708 D LIVE 0001769132 Guide Therapeutics, Inc. 380 NORTHYARDS BLVD. SUITE B, NW ATLANTA GA GEORGIA 30313 404-937-3801 DELAWARE None None Corporation true 2018 Thomas Reese Saylor 380 Northyards Blvd. Suite B, NW Atlanta GA GEORGIA 30313 Executive Officer Director James Dahlman 380 Northyards Blvd. Suite B, NW Atlanta GA GEORGIA 30313 Director Andrew Perlman 380 Northyards Blvd. Suite B, NW Atlanta GA GEORGIA 30313 Director Other Technology Decline to Disclose 06b false 2019-02-15 false true false 0 5000000 2500000 2500000 false 1 0 0 0 false Guide Therapeutics, Inc. /s/ Thomas Reese Saylor Thomas Reese Saylor Chief Executive Officer 2019-02-28